LeonaBio (LONA) Profit After Tax (2019 - 2026)
LeonaBio (LONA) posted quarterly Profit After Tax of -$32.9 million for Q1 2026, down 260.17% year-over-year from $20.6 million in Q1 2025, and up 60.25% quarter-over-quarter from -$82.9 million in Q4 2025.
LeonaBio (LONA) Profit After Tax (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Profit After Tax for 8 consecutive years, with -$32.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax fell 260.17% year-over-year to -$32.9 million; the TTM figure through Mar 2026 stood at -$129.4 million (down 63.07% YoY), while the FY2025 annual figure was -$105.6 million, down 9.34% from the prior year.
- Profit After Tax climbed to -$32.9 million in Q1 2026 per LONA's latest filing, from -$82.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$6.6 million in Q3 2025 and bottomed at -$82.9 million in Q4 2025.
- Historically, Profit After Tax has averaged -$26.3 million across 5 years, with a median of -$26.3 million in 2024.
- On a YoY basis, Profit After Tax climbed as much as 76.97% in 2025 and fell as far as 465.66% in 2025.
- LeonaBio's Profit After Tax stood at -$30.1 million in 2022, then increased by 14.79% to -$25.7 million in 2023, then surged by 42.94% to -$14.7 million in 2024, then slumped by 465.66% to -$82.9 million in 2025, then surged by 60.25% to -$32.9 million in 2026.
- Business Quant data shows LONA's Profit After Tax at -$32.9 million in Q1 2026, -$82.9 million in Q4 2025, and -$6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | -19.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.95 Mn |
| Dec 31, 2025 | -82.89 Mn |
| Sep 30, 2025 | -6.61 Mn |
| Jun 30, 2025 | -6.97 Mn |
| Mar 31, 2025 | -9.15 Mn |
| Dec 31, 2024 | -14.65 Mn |
| Sep 30, 2024 | -28.70 Mn |
| Jun 30, 2024 | -26.86 Mn |
| Mar 31, 2024 | -26.34 Mn |
| Dec 31, 2023 | -25.68 Mn |
| Sep 30, 2023 | -32.97 Mn |
| Jun 30, 2023 | -29.60 Mn |
| Mar 31, 2023 | -27.82 Mn |
| Dec 31, 2022 | -30.14 Mn |
| Sep 30, 2022 | -20.19 Mn |
| Jun 30, 2022 | -24.34 Mn |
| Mar 31, 2022 | -20.98 Mn |
| Dec 31, 2021 | -16.76 Mn |
| Sep 30, 2021 | -15.71 Mn |
| Jun 30, 2021 | -13.97 Mn |